Industry Research Reports
Home > Reports > Service & Software > Global Lyme Disease Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Lyme Disease Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Service & Software
Published Date: 2025-09-10
Pages: 93 Pages
Report ld: 4930627
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Lyme Disease Testing Market Size(US$)
CAGR 2025-2031
6.6%
Market Size,2031
USD 354
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 242 million
Market Forecast in 2031(Value)
US$ 354 million
CAGR
6.6%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Lyme Disease Testing market size was US$ 228 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 6.6% during the forecast period 2025-2031.
Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. Lyme disease is usually diagnosed by serology. RIPL uses a modified 2-tier testing approach. The initial screening test is a combined IgG and IgM ELISA that detects antibodies against 2 Borrelia burgdorferi antigens – VlsE1 and pepC10.
Global key players of Lyme Disease Testing include Quidel Corporation, Roche Holding AG and Fujirebio(H.U. Group Holdings), etc. Global top three manufacturers hold a share about 25%. North America is the largest market of Lyme Disease Testing, with a share over 60%, followed by Asia-Pacific and Europe.
The global Lyme Disease Testing market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- Quidel Corporation
- Roche Holding AG
- Fujirebio(H.U. Group Holdings)
- ZEUS Scientific
- IGeneX
- Thermo Fisher Scientific
- Everlywell
- Oxford Immunotec Global PLC(PerkinElmer)
- BioMerieux
- Bio-Rad Laboratories
- T2 Biosystems
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- ELISA
- Western Blotting
- PCR
- Others
Segment by Application
- Hospital and Testing Agency
- Personal
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Lyme Disease Testing market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Western Blotting in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Personal in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Lyme Disease Testing value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 ELISA
1.2.3 Western Blotting
1.2.4 PCR
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital and Testing Agency
1.3.3 Personal
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lyme Disease Testing Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Lyme Disease Testing Revenue Market Share by Region (2020-2025)
2.4 Global Lyme Disease Testing Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Lyme Disease Testing Market Size and Prospective (2020-2031)
2.5.2 Europe Lyme Disease Testing Market Size and Prospective (2020-2031)
2.5.3 China Lyme Disease Testing Market Size and Prospective (2020-2031)
2.5.4 Japan Lyme Disease Testing Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Lyme Disease Testing Historic Market Size by Type (2020-2025)
3.2 Global Lyme Disease Testing Forecasted Market Size by Type (2026-2031)
3.3 Different Types Lyme Disease Testing Representative Players
4 Breakdown Data by Application
4.1 Global Lyme Disease Testing Historic Market Size by Application (2020-2025)
4.2 Global Lyme Disease Testing Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Lyme Disease Testing Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Lyme Disease Testing Players by Revenue (2020-2025)
5.1.2 Global Lyme Disease Testing Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Lyme Disease Testing Revenue
5.4 Global Lyme Disease Testing Market Concentration Analysis
5.4.1 Global Lyme Disease Testing Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Lyme Disease Testing Revenue in 2024
5.5 Global Key Players of Lyme Disease Testing Head office and Area Served
5.6 Global Key Players of Lyme Disease Testing, Product and Application
5.7 Global Key Players of Lyme Disease Testing, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Lyme Disease Testing Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Lyme Disease Testing Market Size by Type (2020-2025)
6.1.2.2 North America Lyme Disease Testing Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Lyme Disease Testing Market Size by Application (2020-2025)
6.1.3.2 North America Lyme Disease Testing Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Lyme Disease Testing Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Lyme Disease Testing Market Size by Type (2020-2025)
6.2.2.2 Europe Lyme Disease Testing Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Lyme Disease Testing Market Size by Application (2020-2025)
6.2.3.2 Europe Lyme Disease Testing Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Lyme Disease Testing Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Lyme Disease Testing Market Size by Type (2020-2025)
6.3.2.2 China Lyme Disease Testing Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Lyme Disease Testing Market Size by Application (2020-2025)
6.3.3.2 China Lyme Disease Testing Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Lyme Disease Testing Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Lyme Disease Testing Market Size by Type (2020-2025)
6.4.2.2 Japan Lyme Disease Testing Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Lyme Disease Testing Market Size by Application (2020-2025)
6.4.3.2 Japan Lyme Disease Testing Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Quidel Corporation
7.1.1 Quidel Corporation Company Details
7.1.2 Quidel Corporation Business Overview
7.1.3 Quidel Corporation Lyme Disease Testing Introduction
7.1.4 Quidel Corporation Revenue in Lyme Disease Testing Business (2020-2025)
7.1.5 Quidel Corporation Recent Development
7.2 Roche Holding AG
7.2.1 Roche Holding AG Company Details
7.2.2 Roche Holding AG Business Overview
7.2.3 Roche Holding AG Lyme Disease Testing Introduction
7.2.4 Roche Holding AG Revenue in Lyme Disease Testing Business (2020-2025)
7.2.5 Roche Holding AG Recent Development
7.3 Fujirebio(H.U. Group Holdings)
7.3.1 Fujirebio(H.U. Group Holdings) Company Details
7.3.2 Fujirebio(H.U. Group Holdings) Business Overview
7.3.3 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Introduction
7.3.4 Fujirebio(H.U. Group Holdings) Revenue in Lyme Disease Testing Business (2020-2025)
7.3.5 Fujirebio(H.U. Group Holdings) Recent Development
7.4 ZEUS Scientific
7.4.1 ZEUS Scientific Company Details
7.4.2 ZEUS Scientific Business Overview
7.4.3 ZEUS Scientific Lyme Disease Testing Introduction
7.4.4 ZEUS Scientific Revenue in Lyme Disease Testing Business (2020-2025)
7.4.5 ZEUS Scientific Recent Development
7.5 IGeneX
7.5.1 IGeneX Company Details
7.5.2 IGeneX Business Overview
7.5.3 IGeneX Lyme Disease Testing Introduction
7.5.4 IGeneX Revenue in Lyme Disease Testing Business (2020-2025)
7.5.5 IGeneX Recent Development
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Company Details
7.6.2 Thermo Fisher Scientific Business Overview
7.6.3 Thermo Fisher Scientific Lyme Disease Testing Introduction
7.6.4 Thermo Fisher Scientific Revenue in Lyme Disease Testing Business (2020-2025)
7.6.5 Thermo Fisher Scientific Recent Development
7.7 Everlywell
7.7.1 Everlywell Company Details
7.7.2 Everlywell Business Overview
7.7.3 Everlywell Lyme Disease Testing Introduction
7.7.4 Everlywell Revenue in Lyme Disease Testing Business (2020-2025)
7.7.5 Everlywell Recent Development
7.8 Oxford Immunotec Global PLC(PerkinElmer)
7.8.1 Oxford Immunotec Global PLC(PerkinElmer) Company Details
7.8.2 Oxford Immunotec Global PLC(PerkinElmer) Business Overview
7.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Introduction
7.8.4 Oxford Immunotec Global PLC(PerkinElmer) Revenue in Lyme Disease Testing Business (2020-2025)
7.8.5 Oxford Immunotec Global PLC(PerkinElmer) Recent Development
7.9 BioMerieux
7.9.1 BioMerieux Company Details
7.9.2 BioMerieux Business Overview
7.9.3 BioMerieux Lyme Disease Testing Introduction
7.9.4 BioMerieux Revenue in Lyme Disease Testing Business (2020-2025)
7.9.5 BioMerieux Recent Development
7.10 Bio-Rad Laboratories
7.10.1 Bio-Rad Laboratories Company Details
7.10.2 Bio-Rad Laboratories Business Overview
7.10.3 Bio-Rad Laboratories Lyme Disease Testing Introduction
7.10.4 Bio-Rad Laboratories Revenue in Lyme Disease Testing Business (2020-2025)
7.10.5 Bio-Rad Laboratories Recent Development
7.11 T2 Biosystems
7.11.1 T2 Biosystems Company Details
7.11.2 T2 Biosystems Business Overview
7.11.3 T2 Biosystems Lyme Disease Testing Introduction
7.11.4 T2 Biosystems Revenue in Lyme Disease Testing Business (2020-2025)
7.11.5 T2 Biosystems Recent Development
8 Lyme Disease Testing Market Dynamics
8.1 Lyme Disease Testing Industry Trends
8.2 Lyme Disease Testing Market Drivers
8.3 Lyme Disease Testing Market Challenges
8.4 Lyme Disease Testing Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Lyme Disease Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Lyme Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Lyme Disease Testing Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Lyme Disease Testing Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Lyme Disease Testing Revenue Share by Region (2020-2025)
Table 6. Global Lyme Disease Testing Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Lyme Disease Testing Revenue Share Forecast by Region (2026-2031)
Table 8. Global Lyme Disease Testing Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Lyme Disease Testing Revenue Market Share by Type (2020-2025)
Table 10. Global Lyme Disease Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Lyme Disease Testing Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Lyme Disease Testing Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Lyme Disease Testing Revenue Market Share by Application (2020-2025)
Table 15. Global Lyme Disease Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Lyme Disease Testing Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Lyme Disease Testing Application
Table 18. Global Lyme Disease Testing Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Lyme Disease Testing Market Share by Players (2020-2025)
Table 20. Global Top Lyme Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lyme Disease Testing as of 2024)
Table 21. Ranking of Global Top Lyme Disease Testing Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Lyme Disease Testing Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Lyme Disease Testing, Headquarters and Area Served
Table 24. Global Key Players of Lyme Disease Testing, Product and Application
Table 25. Global Key Players of Lyme Disease Testing, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Lyme Disease Testing Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Lyme Disease Testing Revenue Market Share by Company (2020-2025)
Table 29. North America Lyme Disease Testing Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Lyme Disease Testing Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Lyme Disease Testing Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Lyme Disease Testing Revenue Market Share by Company (2020-2025)
Table 33. Europe Lyme Disease Testing Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Lyme Disease Testing Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Lyme Disease Testing Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Lyme Disease Testing Revenue Market Share by Company (2020-2025)
Table 37. China Lyme Disease Testing Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Lyme Disease Testing Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Lyme Disease Testing Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Lyme Disease Testing Revenue Market Share by Company (2020-2025)
Table 41. Japan Lyme Disease Testing Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Lyme Disease Testing Market Size by Application (2020-2025) & (US$ Million)
Table 43. Quidel Corporation Company Details
Table 44. Quidel Corporation Business Overview
Table 45. Quidel Corporation Lyme Disease Testing Product
Table 46. Quidel Corporation Revenue in Lyme Disease Testing Business (2020-2025) & (US$ Million)
Table 47. Quidel Corporation Recent Development
Table 48. Roche Holding AG Company Details
Table 49. Roche Holding AG Business Overview
Table 50. Roche Holding AG Lyme Disease Testing Product
Table 51. Roche Holding AG Revenue in Lyme Disease Testing Business (2020-2025) & (US$ Million)
Table 52. Roche Holding AG Recent Development
Table 53. Fujirebio(H.U. Group Holdings) Company Details
Table 54. Fujirebio(H.U. Group Holdings) Business Overview
Table 55. Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product
Table 56. Fujirebio(H.U. Group Holdings) Revenue in Lyme Disease Testing Business (2020-2025) & (US$ Million)
Table 57. Fujirebio(H.U. Group Holdings) Recent Development
Table 58. ZEUS Scientific Company Details
Table 59. ZEUS Scientific Business Overview
Table 60. ZEUS Scientific Lyme Disease Testing Product
Table 61. ZEUS Scientific Revenue in Lyme Disease Testing Business (2020-2025) & (US$ Million)
Table 62. ZEUS Scientific Recent Development
Table 63. IGeneX Company Details
Table 64. IGeneX Business Overview
Table 65. IGeneX Lyme Disease Testing Product
Table 66. IGeneX Revenue in Lyme Disease Testing Business (2020-2025) & (US$ Million)
Table 67. IGeneX Recent Development
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Lyme Disease Testing Product
Table 71. Thermo Fisher Scientific Revenue in Lyme Disease Testing Business (2020-2025) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Development
Table 73. Everlywell Company Details
Table 74. Everlywell Business Overview
Table 75. Everlywell Lyme Disease Testing Product
Table 76. Everlywell Revenue in Lyme Disease Testing Business (2020-2025) & (US$ Million)
Table 77. Everlywell Recent Development
Table 78. Oxford Immunotec Global PLC(PerkinElmer) Company Details
Table 79. Oxford Immunotec Global PLC(PerkinElmer) Business Overview
Table 80. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product
Table 81. Oxford Immunotec Global PLC(PerkinElmer) Revenue in Lyme Disease Testing Business (2020-2025) & (US$ Million)
Table 82. Oxford Immunotec Global PLC(PerkinElmer) Recent Development
Table 83. BioMerieux Company Details
Table 84. BioMerieux Business Overview
Table 85. BioMerieux Lyme Disease Testing Product
Table 86. BioMerieux Revenue in Lyme Disease Testing Business (2020-2025) & (US$ Million)
Table 87. BioMerieux Recent Development
Table 88. Bio-Rad Laboratories Company Details
Table 89. Bio-Rad Laboratories Business Overview
Table 90. Bio-Rad Laboratories Lyme Disease Testing Product
Table 91. Bio-Rad Laboratories Revenue in Lyme Disease Testing Business (2020-2025) & (US$ Million)
Table 92. Bio-Rad Laboratories Recent Development
Table 93. T2 Biosystems Company Details
Table 94. T2 Biosystems Business Overview
Table 95. T2 Biosystems Lyme Disease Testing Product
Table 96. T2 Biosystems Revenue in Lyme Disease Testing Business (2020-2025) & (US$ Million)
Table 97. T2 Biosystems Recent Development
Table 98. Lyme Disease Testing Market Trends
Table 99. Lyme Disease Testing Market Drivers
Table 100. Lyme Disease Testing Market Challenges
Table 101. Lyme Disease Testing Market Restraints
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Lyme Disease Testing Product Picture
Figure 2. Global Lyme Disease Testing Market Share by Type: 2024 VS 2031
Figure 3. ELISA Features
Figure 4. Western Blotting Features
Figure 5. PCR Features
Figure 6. Others Features
Figure 7. Global Lyme Disease Testing Market Share by Application: 2024 VS 2031
Figure 8. Hospital and Testing Agency
Figure 9. Personal
Figure 10. Lyme Disease Testing Report Years Considered
Figure 11. Global Lyme Disease Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Lyme Disease Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Lyme Disease Testing Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Lyme Disease Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Lyme Disease Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China Lyme Disease Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Japan Lyme Disease Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global Lyme Disease Testing Market Share by Players in 2024
Figure 19. Global Top Lyme Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lyme Disease Testing as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Lyme Disease Testing Revenue in 2024
Figure 21. North America Lyme Disease Testing Market Share by Type (2020-2025)
Figure 22. North America Lyme Disease Testing Market Share by Application (2020-2025)
Figure 23. Europe Lyme Disease Testing Market Share by Type (2020-2025)
Figure 24. Europe Lyme Disease Testing Market Share by Application (2020-2025)
Figure 25. China Lyme Disease Testing Market Share by Type (2020-2025)
Figure 26. China Lyme Disease Testing Market Share by Application (2020-2025)
Figure 27. Japan Lyme Disease Testing Market Share by Type (2020-2025)
Figure 28. Japan Lyme Disease Testing Market Share by Application (2020-2025)
Figure 29. Quidel Corporation Revenue Growth Rate in Lyme Disease Testing Business (2020-2025)
Figure 30. Roche Holding AG Revenue Growth Rate in Lyme Disease Testing Business (2020-2025)
Figure 31. Fujirebio(H.U. Group Holdings) Revenue Growth Rate in Lyme Disease Testing Business (2020-2025)
Figure 32. ZEUS Scientific Revenue Growth Rate in Lyme Disease Testing Business (2020-2025)
Figure 33. IGeneX Revenue Growth Rate in Lyme Disease Testing Business (2020-2025)
Figure 34. Thermo Fisher Scientific Revenue Growth Rate in Lyme Disease Testing Business (2020-2025)
Figure 35. Everlywell Revenue Growth Rate in Lyme Disease Testing Business (2020-2025)
Figure 36. Oxford Immunotec Global PLC(PerkinElmer) Revenue Growth Rate in Lyme Disease Testing Business (2020-2025)
Figure 37. BioMerieux Revenue Growth Rate in Lyme Disease Testing Business (2020-2025)
Figure 38. Bio-Rad Laboratories Revenue Growth Rate in Lyme Disease Testing Business (2020-2025)
Figure 39. T2 Biosystems Revenue Growth Rate in Lyme Disease Testing Business (2020-2025)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Lyme Disease Testing market?
The top companies in the global Lyme Disease Testing market are Quidel Corporation、Roche Holding AG、Fujirebio(H.U. Group Holdings).
What is the annual compound growth rate of the global Lyme Disease Testing market size from 2025 to 2031?
What was the global market size of Lyme Disease Testing in 2031?
Which region is expected to have the highest market share?
What was the global market size of Lyme Disease Testing in 2025?
Related Reports
Global Lyme Disease Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Lyme Disease Testing market size was US$ 242 million in 2025 and is forecast to reach a readjusted size of US$ 375 million by 2032 with a CAGR of 6.6% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 95
USD 4250.00
(Single User License)
Global Lyme Disease Testing Market Research Report 2026
The global Lyme Disease Testing market was valued at US$ 242 million in 2025 and is anticipated to reach US$ 375 million by 2032, at a CAGR of 6.6% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 112
USD 2900.00
(Single User License)
Lyme Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lyme Disease Testing was estimated to be worth US$ 242 million in 2025 and is projected to reach US$ 375 million, growing at a CAGR of 6.6% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 120
USD 3950.00
(Single User License)
Global Lyme Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lyme Disease Testing market is projected to grow from US$ 228 million in 2024 to US$ 354 million by 2031, at a CAGR of 6.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 143
USD 4900.00
(Single User License)
Lyme Disease Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lyme Disease Testing was estimated to be worth US$ 228 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 6.6% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 104
USD 3950.00
(Single User License)
Global Lyme Disease Testing Market Research Report 2025
The global market for Lyme Disease Testing was valued at US$ 228 million in the year 2024 and is projected to reach a revised size of US$ 354 million by 2031, growing at a CAGR of 6.6% during the forecast period.
Published Date: 2025-01-19
Pages: 88
USD 2900.00
(Single User License)
Lyme Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. Lyme disease is usually diagnosed by serology. RIPL uses a modified 2-tier testing approach. The initial screening test is a combined IgG and IgM ELISA that detects antibodies against 2 Borrelia burgdorferi antigens – VlsE1 and pepC10.
Published Date: 2024-01-18
Pages: 103
USD 3950.00
(Single User License)
Global Lyme Disease Testing Market Research Report 2024
Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. Lyme disease is usually diagnosed by serology. RIPL uses a modified 2-tier testing approach. The initial screening test is a combined IgG and IgM ELISA that detects antibodies against 2 Borrelia burgdorferi antigens – VlsE1 and pepC10.
Published Date: 2024-01-03
Pages: 85
USD 2900.00
(Single User License)
Global Lyme Disease Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Lyme Disease Testing market size was US$ 242 million in 2025 and is forecast to reach a readjusted size of US$ 375 million by 2032 with a CAGR of 6.6% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 95
USD 4250.00 (Single User License)Global Lyme Disease Testing Market Research Report 2026
The global Lyme Disease Testing market was valued at US$ 242 million in 2025 and is anticipated to reach US$ 375 million by 2032, at a CAGR of 6.6% from 2026 to 2032.
Published: 2026-01-05
Pages: 112
USD 2900.00 (Single User License)Lyme Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lyme Disease Testing was estimated to be worth US$ 242 million in 2025 and is projected to reach US$ 375 million, growing at a CAGR of 6.6% from 2026 to 2032.
Published: 2026-01-05
Pages: 120
USD 3950.00 (Single User License)Global Lyme Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lyme Disease Testing market is projected to grow from US$ 228 million in 2024 to US$ 354 million by 2031, at a CAGR of 6.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 143
USD 4900.00 (Single User License)Lyme Disease Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lyme Disease Testing was estimated to be worth US$ 228 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 6.6% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 104
USD 3950.00 (Single User License)Global Lyme Disease Testing Market Research Report 2025
The global market for Lyme Disease Testing was valued at US$ 228 million in the year 2024 and is projected to reach a revised size of US$ 354 million by 2031, growing at a CAGR of 6.6% during the forecast period.
Published: 2025-01-19
Pages: 88
USD 2900.00 (Single User License)Lyme Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. Lyme disease is usually diagnosed by serology. RIPL uses a modified 2-tier testing approach. The initial screening test is a combined IgG and IgM ELISA that detects antibodies against 2 Borrelia burgdorferi antigens – VlsE1 and pepC10.
Published: 2024-01-18
Pages: 103
USD 3950.00 (Single User License)Global Lyme Disease Testing Market Research Report 2024
Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. Lyme disease is usually diagnosed by serology. RIPL uses a modified 2-tier testing approach. The initial screening test is a combined IgG and IgM ELISA that detects antibodies against 2 Borrelia burgdorferi antigens – VlsE1 and pepC10.
Published: 2024-01-03
Pages: 85
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now